Bonfiglioli Transmissions’ ₹2,533.66 crore IPO was subscribed 1.91 times as of 10:15 AM on October 19, 2026, the final day of bidding. The issue has a price band of ₹558 to ₹586 per share and closes for subscription today.
The IPO allotment is expected to be finalised on October 21, 2026, with the shares provisionally scheduled to list on the BSE and NSE on October 23, 2026.
The expected IPO schedule is as follows:
|
Event |
Date |
|
Subscription Opening Date |
15 October 2026 |
|
Subscription Closing Date |
19 October 2026 |
|
Basis of Allotment Date |
21 October 2026 |
|
Refund Initiation Date |
22 October 2026 |
|
Credit of Shares |
22 October 2026 |
|
Listing on BSE and NSE |
23 October 2026 |
Note: The allotment and listing dates are tentative and may be revised.
Explore other Upcoming IPOs on BSE and NSE.
[October 19, 2026, 10:15 A.M.]
|
Category |
Subscription (x) |
|
Qualified Institutional Buyers (QIBs) |
0.16x |
|
Non-Institutional Investors (NIIs) |
5.15x |
|
Retail Individual Investors (RIIs) |
1.52x |
|
Employees |
2.59x |
|
Total |
1.91x |
Bonfiglioli Transmissions manufactures precision-engineered gear motors, gearboxes and drive systems for industrial automation, off-highway mobility and wind energy. The Bonfiglioli Group has a presence in 80 countries, supported by 18 production facilities, seven R&D centres and over 550 distributors and resellers. According to the F&S Report, as of June 30, 2026, Bonfiglioli Transmissions was India’s largest manufacturer by operating revenue in the segment for gearboxes rated below 15 kNm and drives used in industrial automation, off-highway mobility and wind energy..
|
Particulars |
For the three month period ended June 30, 2026 (in ₹ crore) |
FY26 (in ₹ crore) |
FY25 (in ₹ crore) |
|
Revenue from operations |
1,131.87 |
960.36 |
2,013.52 |
|
EBITDA |
223.87 |
176.43 |
370.77 |
|
Profit After Tax (PAT) |
148.58 |
114.97 |
237.87 |
Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.
To read the RA disclaimer, please click here